CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 12

Industry reads hand-picked by our editors

May 11, 2025

The New York Times
Elizabeth Holmes’s Partner Has a New Blood-Testing Start-Up
Bloomberg
Asia’s Pharma Stocks Drop as Trump Plans US Drug Price Cuts
The Boston Globe
Mass. residents who take GLP-1 drugs for obesity tend to be white and affluent. But who needs them most?

May 09, 2025

Wired
OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
FirstWord Pharma
AstraZeneca’s Imfinzi hits main goal of bladder cancer study, but survival benefit unclear
The Wall Street Journal
How RFK Jr.’s Rise Could Benefit the ‘Food Babe’ and Other MAHA Acolytes

May 08, 2025

Politico
Trump to pitch sweeping Medicare drug price plan
ProPublica
The Price of Remission
Nature
How protein-slayer drugs could beat some of the cruellest cancers
Barrons
Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

May 07, 2025

Axios
Pharma shipments surge as Trump tariff threat looms
Reuters
Novo Nordisk’s CFO sceptical Trump executive order on drug manufacturing can cut timelines
WBUR
Meet the Mass. doctor chronicling Trump’s impact on health and medicine

May 06, 2025

Bloomberg
Trump-Era Cuts, Harvard Fight Threaten Biotech’s Riskiest Bets
The Washington Post
As RFK Jr. pledges food victories, he faces the realities of governing
Science
‘It’s been a tough period’: NIH’s new director speaks with Science

May 05, 2025

Reuters
US FDA asks some fired pharma user fee negotiation staff to return
Axios
Out-of-pocket drug spending hit $98B in 2024: report
Stat News
NIH use of old vaccine method for universal flu vaccine questioned

May 02, 2025

Fierce Biotech
FDA lifts hold on Amgen’s phase 1 obesity study
FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation
MIT Technology Review
The US has approved CRISPR pigs for food

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by 10x Genomics
Infographic
Accelerate clinical trials: Break silos, reduce delays Custom content for WCG
Survey Report
Data Science Drives 78% Growth in Drug Discovery by 2028 Custom content for Qiagen

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo
Built for the Storm: Why Prepared Systems Win in Pharma Webinar - on demand • Provided by Phase2
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.